Sale of 7.7 g of Radium-226 for medical applications
Published deadline passed
The published deadline has passed. For multi-stage competitions a later tender deadline may still apply — check the notice or portal for the current phase.
- Qualification deadline
- Sep 18,Expired
- Award
- Price only
Brief
Europäische Kommission, Gemeinsame Forschungsstelle (JRC) needs to sell approximately 7.7 grams of Radium-226 (Ra-226) over 3 years for cutting-edge research and development in nuclear medical applications, including the production of Actinium-225 (Ac-225) and Lead-212 (Pb-212). The sale aims to bolster the availability of Ra-226 for medical applications and advance nuclear medicine. The award criteria is price (100%).
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Please consult the procurement documents.
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Europäische Kommission, DG COMM - Communication
From the notice
The European Commission, Joint Research Centre (JRC) in Karlsruhe (Germany) plans to sell approximately 7.7 grams of Radium-226 (Ra-226), a valuable resource from its our strategic inventory utilised for cutting-edge research and development in nuclear medical applications. This includes applications in the production of Actinium-225 (Ac-225) for the use of targeted alpha therapy. Following a surge of demand for Ac-225, Ra-226 material serves as a crucial source material for producing it as well as other valuable medical radioisotopes, such as Lead-212 (Pb-212). With a growing demand and limited supply for Ra-226, the JRC Karlsruhe wants to contribute to the medical isotope supply chain. The expertise along with the state-of-the-art assets at JRC Karlsruhe, equips it to contribute effectively to this critical field. This sale is meant to bolster the availability of Ra-226 for medical applications and further the advancement of nuclear medicine.
Contact
jrc-procurement-karlsruhe@ec.europa.eu- Competition · PrequalificationType
- 09343000Main codeRadioactive materials